INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Systematic review / meta-analysis / 2019

Clinical studies link mushroom-derived lentinan to benefits during conventional cancer therapy.

A systematic review evaluated 135 clinical studies from China comprising 9,474 cancer treatment cases involving the shiitake polysaccharide lentinan. Most cases involved lung (3,469), gastric (3,039), or colorectal (1,646) malignancies. Across evaluated reports, lentinan use was linked to better quality of life and greater efficacy of concurrent chemotherapy or radiation treatment.

Study type
Systematic review of clinical studies
Who was studied
9,474 cancer cases across 135 clinical studies, China
What was measured
Quality of life and cancer treatment efficacy

THE PAPER

Mushroom polysaccharide lentinan for treating different types of cancers: A review of 12 years clinical studies in China.

Zhang M, Zhang Y, Zhang L, Tian Q. Prog Mol Biol Transl Sci, 2019.

PubMed 31030752 ↗DOI 10.1016/bs.pmbts.2019.02.013 ↗

CancerTop 21: Mushrooms

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.